https://www.selleckchem.com/pr....oducts/adenosine-5-d
017). TXA was associated with a HLOS reduction of 0.9 days (β-coefficient -0.582, 95% CI -1.008- -0.156, p=0.008), an increased likelihood of hospital discharge over skilled nursing facility (SNF) (OR 2.25, 95% CI 1.117-4.531, p=0.023) and reduced total hospital cost of care by 6.45% (p less then 0.001), room and board costs by 11.76% (p less then 0.001), and transfusion costs by 81.65% (p less then 0.001). In conclusion, TXA use in bilateral TKA is associated with lower blood transfusion rates, reduced hospi
Like
Comment
Share
